Skip to main content
. 2023 Oct 17;13:17607. doi: 10.1038/s41598-023-44973-z

Table 4.

Two-by-two contingency table for disproportionality analysis.

Number of reports Interest AEs All other AEs
Drug of interest A B
All other drugs (or all mAbs) C D

The number of reports included in A: both target drugs and specific AEs; B: target drug AEs but with all other AEs; C: specific AEs but with all other drugs; D: all other drugs and all other AEs.